Accuracy of rapid test for diagnosis of hepatitis A with different infection rate settings and with predictive modeling

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Organization WH. Weekly epidemiological record. WHO Position Paper on Hepatitis A Vaccines – June 2012 87, 261–276 (2012).
  Google Scholar
• 2 Walker BW. Hepatitis A infection: on alert for outbreaks. Nursing 48(4), 66–69 (2018). • Focuses on recent hepatitis A outbreak that underscore the needs for an understanding of the disease, identification of signs, diagnosis and prevention.
  MedlineGoogle Scholar
• 3 Lemon SM, Ott JJ, Van Damme P, Shouval D. Type A viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J. Hepatol. doi:10.1016/j.jhep.2017.08.034 (2017) (Epub ahead of print). • Summarizes recent advances in the molecular virology of hepatitis A virus (HAV), survey what is known of the pathogenesis of hepatitis A (HA) in humans and the host-pathogen interactions that typify the infection, and review medical and public health 667 aspects of immunization and disease prevention.
  MedlineGoogle Scholar
• 4 Lima LR, De Almeida AJ, Tourinho Rdos S, Hasselmann B, Ximenez LL, De Paula VS. Evidence of hepatitis A virus person-to-person transmission in household outbreaks. PLoS ONE 9(7), e102925 (2014).
  MedlineGoogle Scholar
• 5 Yong HT, Son R. Hepatitis A virus – a general overview. Int. Food Res. J. 16, 455–467 (2009).
  CASGoogle Scholar
• 6 Mcknight KL, Lemon SM. Hepatitis A virus genome organization and replication strategy. Cold Spring Harb. Perspect. Med. 8(12), pii:a033480 (2018).
  MedlineGoogle Scholar
• 7 Provost PJ, Wolanski BS, Miller WJ, Ittensohn OL, Mcaleer WJ, Hilleman MR. Physical, chemical and morphologic dimensions of human hepatitis A virus strain CR326 (38578). In: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine. NY, USA 148(2), 532–539 (1975).
  Google Scholar
• 8 Murphy TV, Denniston MM, Hill HA et al. Progress toward eliminating hepatitis A disease in the United States. MMWR Supplements 65(1), 29–41 (2016).
  MedlineGoogle Scholar
• 9 Shin EC, Jeong SH. Natural history, clinical manifestations, and pathogenesis of Hepatitis A. Cold Spring Harb. Perspect. Med. 8(9), pii:a031708 (2018).
  Google Scholar
• 10 Ciocca M, Ramonet M, Cuarterolo M, Lopez S, Cernadas C, Alvarez F. Prognostic factors in paediatric acute liver failure. Arch. Dis. Child. 93(1), 48–51 (2008).
  Medline CASGoogle Scholar
• 11 Ciocca M, Moreira-Silva SF, Alegria S et al. Hepatitis A as an etiologic agent of acute liver failure in Latin America. Pediatr. Infect. Dis. J. 26(8), 711–715 (2007).
  MedlineGoogle Scholar
• 12 Centeno MA, Bes DF, Sasbon JS. Mortality risk factors of a pediatric population with fulminant hepatic failure undergoing orthotopic liver transplantation in a pediatric intensive care unit. Pediatr. Crit. Care Med. 3(3), 227–233 (2002).
  MedlineGoogle Scholar
• 13 Brasil MS. Boletim Epidemiológico – Hepatites Virais. Boletim de Hepatites 48(68), 9–13 (2017).
  Google Scholar
• 14 Vitral CL, Ospina FL, Artimos S et al. Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil. Memorias do Instituto Oswaldo Cruz 107(5), 652–658 (2012).
  MedlineGoogle Scholar
• 15 Ximenes RA, Pereira LM, Martelli CM et al. Methodology of a nationwide cross-sectional survey of prevalence and epidemiological patterns of hepatitis A, B and C infection in Brazil. Cadernos de saude publica 26(9), 1693–1704 (2010).
  MedlineGoogle Scholar
• 16 Platform SDK. Sustainable Development Goal 3: ensure healthy lives and promote well-being for all at all ages. https://sustainabledevelopment.un.org/sdg3 (2017) (accessed 20 December 2018).
  Google Scholar
• 17 World Health Organization. Global health sector strategy on viral hepatitis 2016–2021: towards ending viral hepatitis 2016 (2016) (accessed 20 December 18). www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/.
  Google Scholar
• 18 Standard Diagnostics. SD BIOLINE HAV IgG/IgM. One step IgG and IgM antibodies to Hepatitis A virus rapid test (2013). www.standardia.com.
  Google Scholar
• 19 Bower WA, Nainan OV, Han X, Margolis HS. Duration of viremia in hepatitis A virus infection. J. Infect. Dis. 182(1), 12–17 (2000).
  Medline CASGoogle Scholar
• 20 Amado LA, Marchevsky RS, De Paula VS et al. Experimental hepatitis A virus (HAV) infection in cynomolgus monkeys (Macaca fascicularis): evidence of active extrahepatic site of HAV replication. Int. J. Exp. Pathol. 91(1), 87–97 (2010).
  Medline CASGoogle Scholar
• 21 Altman DG. Statistics in medical journals: developments in the 1980s. Stats. Med. 10(12), 1897–1913 (1991).
  Medline CASGoogle Scholar
• 22 Cha YJ, Park Q, Kang ES et al. Performance evaluation of the OraQuick hepatitis C virus rapid antibody test. Ann. Lab. Med. 33(3), 184–189 (2013).
  Medline CASGoogle Scholar
• 23 Scheiblauer H, El-Nageh M, Nick S, Fields H, Prince A, Diaz S. Evaluation of the performance of 44 assays used in countries with limited resources for the detection of antibodies to hepatitis C virus. Transfusion 46(5), 708–718 (2006). •• This study was conducted by the International Consortium for Blood Safety and its Collaborating Center, to identify high-quality, affordable assays for the detection of HCV antibodies and make available information on their performance for the benefit of developing countries.
  Medline CASGoogle Scholar
• 24 Lee HJ, Jeong HS, Cho BK et al. Evaluation of an immunochromatographic assay for the detection of anti-hepatitis A virus IgM. Virol. J. 7, 164 (2010). •• The author developed a rapid assay based on immunochromatography and evaluated the sensitivity of this assay by comparing it with a commercial microparticle enzyme immunoassay that is widely used for serological diagnosis.
  MedlineGoogle Scholar
• 25 Naz A, Zahid D, Murky SN, Nadeem M, Sil BK, Shamsi TS. Evaluation of efficacy of various immunochromatographic rapid tests for dengue diagnosis. Pak. J. Med. Sci. 30(1), 166–171 (2014).
  MedlineGoogle Scholar
• 26 Scalioni Lde P, Cruz HM, De Paula VS et al. Performance of rapid hepatitis C virus antibody assays among high- and low-risk populations. J. Clin Virol. 60(3), 200–205 (2014).
  MedlineGoogle Scholar
• 27 Cruz HM, Scalioni Lde P, De Paula VS et al. Evaluating HBsAg rapid test performance for different biological samples from low and high infection rate settings & populations. BMC Infect. Dis. 15, 548 (2015).
  MedlineGoogle Scholar
• 28 Ximenes RA, Martelli CM, Amaku M et al. Modelling the force of infection for hepatitis A in an urban population-based survey: a comparison of transmission patterns in Brazilian macro-regions. PLoS ONE 9(5), e94622 (2014). • This study findings support the shift of Brazil toward intermediate and low endemicity levels with the shift of the risk of infection to older age groups. These estimates of HA force of infection stratified by age and endemicity levels are useful information to characterize the HA scenario in Brazil.
  MedlineGoogle Scholar